• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Marrone Bio Innovations, Inc. (Amendment)

    7/9/21 2:37:31 PM ET
    $MBII
    Major Chemicals
    Basic Industries
    Get the next $MBII alert in real time by email
    SC 13G/A 1 d203229dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 4)*

     

     

    Marrone Bio Innovations, Inc.

    (Name of Issuer)

    Common Shares

    (Title of Class of Securities)

    57165B106

    (CUSIP Number)

    June 30, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 57165B106  

     

      1.   

    Names of Reporting Persons

     

    Macquarie Group Limited

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☒        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Citizenship or Place of Organization

     

    Sydney, New South Wales Australia

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5.    

    Sole Voting Power

     

    0

       6.   

    Shared Voting Power

     

    0

       7.   

    Sole Dispositive Power

     

    0

       8.   

    Shared Dispositive Power

     

    0

      9.  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    20,092,701 deemed beneficially owned due to reporting person’s ownership of Macquarie Bank Limited, Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust whose individual holdings are shown on the following forms.

    10.  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

    ☐

    11.  

    Percent of Class Represented by Amount in Row (9)

     

    11.46%

    12.  

    Type of Reporting Person (See Instructions)

     

    HC

     

    Page 2 of 12


    CUSIP No. 57165B106  

     

      1.   

    Names of Reporting Persons

     

    Macquarie Bank Limited

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☒        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Citizenship or Place of Organization

     

    Sydney, New South Wales, Australia

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5.    

    Sole Voting Power

     

    0

       6.   

    Shared Voting Power

     

    0

       7.   

    Sole Dispositive Power

     

    0

       8.   

    Shared Dispositive Power

     

    0

      9.  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    20,092,701 deemed beneficially owned due to reporting person’s ownership of Macquarie Funds Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust whose individual holdings are shown on the following forms.

    10.  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

    ☐

    11.  

    Percent of Class Represented by Amount in Row (9)

     

    11.46%

    12.  

    Type of Reporting Person (See Instructions)

     

    CO

     

    Page 3 of 12


    CUSIP No. 57165B106  

     

      1.   

    Names of Reporting Persons

     

    Macquarie Management Holdings Inc.

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☒        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Citizenship or Place of Organization

     

    State of Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5.    

    Sole Voting Power

     

    20,092,701

       6.   

    Shared Voting Power

     

    0

       7.   

    Sole Dispositive Power

     

    20,092,701

       8.   

    Shared Dispositive Power

     

    0

      9.  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    20,092,701 deemed beneficially owned due to reporting person’s ownership of Macquarie Investment Management Business Trust

    10.  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

    ☒

    11.  

    Percent of Class Represented by Amount in Row (9)

     

    11.46%

    12.  

    Type of Reporting Person (See Instructions)

     

    HC

     

    Page 4 of 12


    CUSIP No. 57165B106  

     

      1.   

    Names of Reporting Persons

     

    Macquarie Investment Management Business Trust

      2.  

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a)  ☒        (b)  ☐

     

      3.  

    SEC Use Only

     

      4.  

    Citizenship or Place of Organization

     

    State of Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       5.    

    Sole Voting Power

     

    20,092,701

       6.   

    Shared Voting Power

     

    0

       7.   

    Sole Dispositive Power

     

    20,092,701

       8.   

    Shared Dispositive Power

     

    0

      9.  

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    20,092,701

    10.  

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

     

    ☒

    11.  

    Percent of Class Represented by Amount in Row (9)

     

    11.46%

    12.  

    Type of Reporting Person (See Instructions)

     

    IA

     

    Page 5 of 12


    Item 1.

     

      

    (a)

      

    Name of Issuer
    Marrone Bio Innovations, Inc.

      

    (b)

      

    Address of Issuer’s Principal Executive Offices
    1540 Drew Ave Davis, CA 95618

     

    Item 2.

     

      

    (a)

      

    Name of Person Filing
    This Schedule 13G is jointly filed by Macquarie Group Limited, Macquarie Bank Limited, Macquarie Management Holdings Inc., Macquarie Investment Management Business Trust

      

    (b)

      

    Address of Principal Business Office or, if none, Residence
    The principal business address of Macquarie Group Limited and Macquarie Bank Limited is 50 Martin Place Sydney, New South Wales, Australia. The principal business address of Macquarie Management Holdings Inc and Macquarie Investment Management Business Trust is 2005 Market Street, Philadelphia, PA 19103.

      

    (c)

      

    Citizenship
    Macquarie Group Limited, Macquarie Bank Limited - Sydney, New South Wales, Australia Corporation

    Macquarie Investment Management Business Trust and Macquarie Management Holdings Inc – incorporated or formed under the laws of the State of Delaware.

      

    (d)

      

    Title of Class of Securities
    Common Stock

      

    (e)

      

    CUSIP Number
    57165B106

     

    Item 3.

     

      

     

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      

    (a)

      

    ☐

       Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
      

    (b)

      

    ☐

       Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
      

    (c)

      

    ☐

       Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
      

    (d)

      

    ☐

       Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      

    (e)

      

    ☒

       An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
      

    (f)

      

    ☐

       An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
      

    (g)

      

    ☒

       A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
      

    (h)

      

    ☐

       A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      

    (i)

      

    ☐

       A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      

    (j)

      

    ☐

       A non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J);
      

    (k)

      

    ☐

       Group, in accordance with § 240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d–1(b)(1)(ii)(J), please specify the type of institution:                        

     

    Page 6 of 12


    Item 4.

      

    Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

       (a)   

    Amount beneficially owned:

    See responses on the cover page hereto.

       (b)   

    Percent of class:

    See responses on the cover page hereto.

       (c)   

    Number of shares as to which the person has:

          (i)   

    Sole power to vote or to direct the vote

    See responses on the cover page hereto.

          (ii)   

    Shared power to vote or to direct the vote

    0

          (iii)   

    Sole power to dispose or to direct the disposition of

    See responses on the cover page hereto.

          (iv)   

    Shared power to dispose or to direct the disposition of

    0

     

    Item 5.

      

     Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following

     

    Item 6.

      

     Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7.

        Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

    See Exhibit A.

     

    Item 8.

      

     Identification and Classification of Members of the Group

    Not applicable.

     

    Item 9.

      

     Notice of Dissolution of Group

    Not applicable.

     

    Page 7 of 12


    Item 10.

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Macquarie Group Limited

      

    July 9, 2021

       Date

    /s/ Paul Peduto

      

    /s/ Charles Glorioso

    Signature    Signature

     

    Paul Peduto

    Associate Director

      

     

    Charles Glorioso

    Division Director

     

    Macquarie Bank Limited

      

    July 9, 2021

       Date

    /s/ Paul Peduto

      

    /s/ Charles Glorioso

    Signature    Signature

     

    Paul Peduto

    Associate Director

      

     

    Charles Glorioso

    Division Director

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Macquarie Management Holdings, Inc.

      

    July 9, 2021

       Date

    /s/ Brian L. Murray

      
    Signature   

     

    Brian L. Murray

    Chief Compliance Officer

      

     

    Macquarie Investment Management Business Trust

      

    July 9, 2021

       Date

    /s/ Brian L. Murray

      
    Signature   

     

    Brian L. Murray

    Chief Compliance Officer

      

     

    Page 8 of 12


    EXHIBIT A

    AGREEMENT TO FILE JOINT ACQUISITION STATEMENTS

    AGREEMENT made this 2nd day of FEBRUARY, 2021 by and between Delaware Funds® by Macquarie listed on Annex A hereto, Macquarie Investment Management Business Trust, Macquarie Management Holdings, Inc, and the Macquarie Parties listed on Annex B hereto (collectively referred to as the “parties”).

    WHEREAS, the parties hereto may be deemed to be the direct or indirect beneficial owners of the same equity securities for the purpose of the reporting requirements of Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and

    WHEREAS, the regulations promulgated under Section 13(d) of the Exchange Act permit the joining of such beneficial owners in the filing of a single Joint Acquisition Statement reporting such ownership to the Securities and Exchange Commission.

    NOW, THEREFORE, in consideration of the mutual covenants herein contained, and each of the parties hereto intending to be legally bound, it is agreed as follows:

    1.    In the event that any two or more parties shall be deemed to be the direct or indirect beneficial owners of the same equity security required to be reported to the Securities and Exchange Commission such parties may join together in the filing of a Joint Acquisition Statement with respect to that security. Additional persons who may after the date hereof be deemed to be the direct or indirect beneficial owners of the same equity security as a party hereto and required to be reported to the Securities and Exchange Commission (a “New Party”) may be added as a party this agreement by signing a counterpart hereof. An amendment to this agreement is deemed effective upon the signature of such new party and the amendment of the applicable Annex which may be affixed to this agreement as amended. Each party hereto agrees that this agreement, as it may be amended from time to time as provided herein, is a valid and binding agreement of each such party.

    2.    With respect to each Joint Acquisition Statement in which a party joins, each party acknowledges that (a) it will be eligible under applicable regulations of the Securities and Exchange Commission to join in the filing and (b) it will be responsible for the timely filing of such statement and any amendments thereto and the completeness and accuracy of the information concerning such party; but each such party shall not be responsible for the completeness and accuracy of the information concerning the other parties making the filing, unless such party knows or has reason to believe that such information with respect to such other parties is inaccurate.

    3.    The parties consent to the inclusion of a copy of this agreement as an exhibit to any Joint Acquisition Statement filed on behalf of any of them.

     

    Page 9 of 12


    IN WITNESS WHEREOF, the parties hereto have executed this agreement by their duly authorized officers as of the date set forth above.

    DELAWARE FUNDS® BY MACQUARIE (listed on Annex A hereto)

    ATTEST BY:

     

    /s/ Brian L. Murray

      

    /s/ David Connor

    Signature

     

      

    Signature

     

     

    Brian L. Murray

    Chief Compliance Officer

      

     

    David Connor

    General Counsel

    MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST

     

    /s/ Brian L. Murray

      

    /s/ David Connor

    Signature

     

      

    Signature

     

    Brian L. Murray

    Chief Compliance Officer

      

    David Connor

    General Counsel

    MACQUARIE MANAGEMENT HOLDINGS, INC.

     

    /s/ Brian L. Murray

      

    /s/ David Connor

    Signature

     

      

    Signature

     

    Brian L. Murray

    Chief Compliance Officer

      

    David Connor

    General Counsel

    THE MACQUARIE PARTIES (LISTED ON ANNEX B HERETO)

    ATTEST BY:

     

    /s/ Paul Peduto

      

    /s/ Charles Glorioso

    Signature

     

      

    Signature

     

    Paul Peduto

    Associate Director

      

    Charles Glorioso

    Division Director

     

    Page 10 of 12


    Annex A— Delaware FundsSM by Macquarie

    DELAWARE GROUP EQUITY FUNDS I

    DELAWARE GROUP EQUITY FUNDS II

    DELAWARE GROUP EQUITY FUNDS IV

    DELAWARE GROUP EQUITY FUNDS V

    DELAWARE GROUP INCOME FUNDS

    DELAWARE GROUP LIMITED-TERM GOVERNMENT FUNDS

    DELAWARE GROUP CASH RESERVE

    DELAWARE GROUP GOVERNMENT FUND

    DELAWARE GROUP STATE TAX-FREE INCOME TRUST

    DELAWARE GROUP TAX-FREE FUND

    DELAWARE GROUP GLOBAL & INTERNATIONAL FUNDS

    DELAWARE GROUP ADVISER FUNDS

    DELAWARE VIP TRUST

    DELAWARE POOLED TRUST

    DELAWARE GROUP FOUNDATION FUNDS

    DELAWARE INVESTMENTS DIVIDEND AND INCOME FUND, INC.

    DELAWARE ENHANCED GLOBAL DIVIDEND AND INCOME FUND

    INVESTED PORTFOLIOS

    IVY HIGH INCOME OPPORTUNITIES FUND

    IVY FUNDS

    IVY VARIABLE INSURANCE PORTFOLIOSSM

    VOYAGEUR INSURED FUNDS

    VOYAGEUR INTERMEDIATE TAX FREE FUNDS

    VOYAGEUR MUTUAL FUNDS

    VOYAGEUR MUTUAL FUNDS II

    VOYAGEUR MUTUAL FUNDS III

    VOYAGEUR TAX FREE FUNDS

    DELAWARE INVESTMENTS COLORADO MUNICIPAL INCOME FUND, INC.

    DELAWARE INVESTMENTS NATIONAL MUNICIPAL INCOME FUND

    DELAWARE INVESTMENTS MINNESOTA MUNICIPAL INCOME FUND II, INC.

     

    Page 11 of 12


    Annex B — the Macquarie Parties

    Macquarie Group Limited

    Macquarie Bank Limited

    Macquarie Affiliated Managers (USA) Inc.

    Macquarie Affiliated Managers Holdings (USA) Inc.

    Macquarie Americas Holdings Pty Ltd.

    Macquarie B.H. Pty Limited

    Macquarie FG Holdings Inc.

    Macquarie Funding Holdings LLC

    Macquarie Investment Management Europe Limited

    EXHIBIT B

    Powers of Attorney for Macquarie Group Limited and Macquarie Bank Limited incorporated by reference to 13G filings made by Macquarie Group Limited and Macquarie Bank Limited on May 25, 2021.

     

    Page 12 of 12

    Get the next $MBII alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MBII

    DatePrice TargetRatingAnalyst
    9/22/2021$2.00Buy
    Roth Capital
    8/19/2021$3.50 → $2.50Buy
    Aegis Capital
    More analyst ratings

    $MBII
    SEC Filings

    See more
    • SEC Form 15-12G filed by Marrone Bio Innovations Inc.

      15-12G - Pro Farm Group, Inc. (0001441693) (Filer)

      9/2/22 6:17:10 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form EFFECT filed by Marrone Bio Innovations Inc.

      EFFECT - Pro Farm Group, Inc. (0001441693) (Filer)

      8/30/22 12:15:26 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form EFFECT filed by Marrone Bio Innovations Inc.

      EFFECT - Pro Farm Group, Inc. (0001441693) (Filer)

      8/30/22 12:15:28 AM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Roth Capital initiated coverage on Marrone Bio Innovations with a new price target

      Roth Capital initiated coverage of Marrone Bio Innovations with a rating of Buy and set a new price target of $2.00

      9/22/21 11:59:03 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Aegis Capital reiterated coverage on Marrone Bio Innovations with a new price target

      Aegis Capital reiterated coverage of Marrone Bio Innovations with a rating of Buy and set a new price target of $2.50 from $3.50 previously

      8/19/21 9:34:56 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Canaccord Genuity resumed coverage on Marrone Bio Innovations with a new price target

      Canaccord Genuity resumed coverage of Marrone Bio Innovations with a rating of Buy and set a new price target of $3.50

      3/5/21 7:31:59 AM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Vasavada Amit was granted 129,184 shares and returned 285,892 shares to the company, closing all direct ownership in the company

      4 - MARRONE BIO INNOVATIONS INC (0001441693) (Issuer)

      7/15/22 11:15:05 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form 4: Johnson Timothy B was granted 102,167 shares and returned 212,374 shares to the company, closing all direct ownership in the company

      4 - MARRONE BIO INNOVATIONS INC (0001441693) (Issuer)

      7/15/22 11:13:32 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form 4 filed by Ospraie Ag Science Llc

      4 - MARRONE BIO INNOVATIONS INC (0001441693) (Issuer)

      7/15/22 9:09:02 AM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    Leadership Updates

    Live Leadership Updates

    See more
    • 180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors

      MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it has appointed Pamela Marrone, PhD, and Frank Knuettel II, MBA, to its Board of Directors (“Board”) effective upon the earlier of (a) the business day following the filing of the 2020 Form 10-K Annual Report; and (b) June 28, 2021. The Board also changed the effective dates of the appointments of Russell T. Ray, MBA and Teresa DeLuca MD, MBA as members of the Board, as previously announced

      6/10/21 9:12:32 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Marrone Bio Appoints Sue Cheung New Chief Financial Officer

      DAVIS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that Suping (Sue) Cheung has been appointed chief financial officer, effective Feb. 18, 2021. She succeeds James Boyd, who previously announced his intention to retire. Cheung, a certified public accountant, brings to Marrone Bio 28 years of experience in international strategic and financial operations, including financial reporting, forecasting and budgeting; mergers and acquisitions; equity and debt financing; internal controls; and inves

      1/28/21 9:00:00 AM ET
      $QUIK
      $MBII
      Semiconductors
      Technology
      Major Chemicals
      Basic Industries

    $MBII
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MBII
    Financials

    Live finance-specific insights

    See more

    $MBII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions

      ROTH MKM ("Roth"), www.roth.com, a relationship-driven investment bank focused on serving growth companies and their investors, is pleased to announce that their agribusiness investment banking group has advised on three sellside transactions in the past nine months. The transactions included business models in the areas of cover crops, gene editing, biologicals, bio stimulants, and alternative fertilizers, and demonstrate the group's expertise in designing and executing M&A processes to achieve the best outcomes for its clients in a wide array of agriculture related sectors. ROTH MKM's Agribusiness Investment Banking Group served as the sellside advisor on the following transactions:

      4/11/23 9:00:00 AM ET
      $BG
      $BIOX
      $CTVA
      $CVX
      Packaged Foods
      Consumer Staples
      Agricultural Chemicals
      Industrials
    • Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions

      Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today the successful completion of its previously announced integration of Marrone Bio Innovations, Inc. (NASDAQ:MBII) ("MBI"). "The completion of this transaction represents an important milestone in our journey, cementing our leadership in the development and commercialization of sustainable agricultural solutions," said Bioceres Chief Executive Officer, Federico Trucco. "MBI brings 15 years of experience in the development of biological solutions, and we are excited to a

      7/12/22 4:43:00 PM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.

      RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI's stockholders approved the adoption of the Merger Agreement and approved on a non-binding advisory basis certain executive compensation that may be paid or become payable in connection with the merger contemplated by t

      7/11/22 8:30:00 AM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results

      RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in the first half are expected to increase in the low- to mid-teens on a percentage basis.Gross profit of $6.2 million and gross margins of 55.9% reflected changes in product mix, higher raw material

      5/11/22 4:01:00 PM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time

      RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovations' first quarter financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information: Q1 2022 Conference Call and Webcast Date: Wednesday, May 11, 2022Time: 4:30 p.m

      4/27/22 8:00:00 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results

      RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include: Full year revenues rose 15.5%, with a 40.2% increase in the fourth quarter.Gross profit grew 19.1% and 31.5% for the full year and fourth quarter, respectively, with margins exceeding 59% in both periods.For the full year, net loss was $16.6 million and Adjusted EBITDA1 loss was $8.7 million, improvements of 17.9% and 21.2%, respectively.As announced March 16, 2022, Marrone Bio and Bioceres Crop So

      3/28/22 4:01:00 PM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries
    • SEC Form SC 13D/A filed by Marrone Bio Innovations Inc. (Amendment)

      SC 13D/A - MARRONE BIO INNOVATIONS INC (0001441693) (Subject)

      7/15/22 9:12:06 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form SC 13G/A filed by Marrone Bio Innovations Inc. (Amendment)

      SC 13G/A - MARRONE BIO INNOVATIONS INC (0001441693) (Subject)

      3/29/22 11:21:42 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form SC 13G/A filed by Marrone Bio Innovations Inc. (Amendment)

      SC 13G/A - MARRONE BIO INNOVATIONS INC (0001441693) (Subject)

      2/14/22 12:25:35 PM ET
      $MBII
      Major Chemicals
      Basic Industries